Study offers clues to cause of kids' br... ( Insights from a genetic condition th...)

Study offers clues to cause of kids' brain tumors

Date:11/16/2012

Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.

In new research, scientists at Washington University School of Medicine in St. Louis have identified a cell growth pathway that is unusually active in pediatric brain tumors known as gliomas. They previously identified the same growth pathway as a critical contributor to brain tumor formation and growth in neurofibromatosis-1 (NF1), an inherited cancer predisposition syndrome.

"This suggests that the tools we've been developing to diagnose and treat NF1 may also be helpful for sporadic brain tumors," says senior author David H. Gutmann, MD, PhD, the Donald O. Schnuck Family Professor of Neurology.

The findings appear Dec. 1 in Genes and Development.

NF1 is among the most common tumor predisposition syndromes, but it accounts for only about 15 percent of pediatric low-grade gliomas known as pilocytic astrocytomas. The majority of these brain tumors occur sporadically in people without NF1.

Earlier research showed that most sporadic pilocytic astrocytomas possess an abnormal form of a signaling protein known as BRAF. In tumor cells, a piece of another protein is erroneously fused to the business end of BRAF.

Scientists suspected that the odd protein fusion spurred cells to grow and divide more often, leading to tumors. However, when they gave mice the same aberrant form of BRAF, they observed a variety of results. Sometimes gliomas formed, but in other cases, there was no discernible effect or a brief period of increased growth and cell division. In other studies, the cells grew old and died prematurely.

Gutmann, director of the Washington University Neurofibromatosis Center, previously showed that mouse NF1-associated gliomas arise from certain brain cells.

According to Gutmann, the impact of abnormal NF1 gene function on particular ce
'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds

Post Your Comments:

(Date:5/23/2013)... 23, 2013 The Rottenstein Law Group ... has created the Tylenol Lawsuit Information Center at ... users and those who are considering filing lawsuits. ... potentially cause severe liver damage, according to a 2009 ... In the “safety communication,” the FDA warned consumers against ...

(Date:5/23/2013)... Spring and summer have always been motivation for people ... the city between Memphis and Nashville? In the last year ... has transformed the growing area into one of the most ... of vibrant, young professionals you are going to see demand ... owner of The Fight Shop, one of the city’s hottest ...

(Date:5/23/2013)... Concert Tickets announces that Paul McCartney will be ... America. This well known ticket website has slashed prices ... McCartney fans see Sir Paul live in concert. Jan, ... also offering the customer appreciation code SAVE for additional savings ... is also a huge McCartney fan and plans to see ...

(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Teen birth rates in ... according to a new government report. Overall, the rate ... nearly one half from 1991 to 2011 -- from about ... every 1,000. From 2007 to 2011, the most recent ... about 31. During that time, rates fell at least ...

(Date:5/23/2013)... that an immune regulatory molecule called IL-21 is needed ... , The results are published in the Journal ... could be important in the development of antiviral vaccines," ... first author of the paper. The senior author is ... and a Georgia Research Alliance Eminent Scholar. , The ...

Breaking Medicine News(10 mins):Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2 Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2 Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3 Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4 Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2 Health News:U.S. Teen Birth Rate Plummets: Report 2 Health News:U.S. Teen Birth Rate Plummets: Report 3 Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2

[0] Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center [0] Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee [0] Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle [0] U.S. Teen Birth Rate Plummets: Report [0] Vaccine blackjack: IL-21 critical to fight against viral infections

... Eating Tips to Stay Balanced Through the ... ... Registered dietitian, celebrity,chef, and New York Times best-selling author Ellie Krieger, ... the benefits of,digestive health. Yo-Plus contains live and active probiotic cultures,specifically ...

... N.C., Nov. 5 Cornerstone Therapeutics,Inc. (Nasdaq ... on,developing and commercializing prescription medications for respiratory,disorders, ... of the recently,completed merger between Cornerstone BioPharma ... Collard, 42, president and chief executive,officer and ...

... 5 CardiacAssist, Inc. announced that,it reached a new high ... least one TandemHeart case during the third quarter of 2008.,In ... on,year growth in case activity with a leap of 64 ... and 497 %. Through nine months of 2008,CardiacAssist has also ...

... Corporate Highlights:, -- Net service revenues increased 84% to $58.7 ... to $48.6 million -- Net income increased 149% to $4.7 ... share on 49% more shares -- Completed acquisition of Patient ... 200 Best Small Companies List, Almost Family, Inc. (Nasdaq: ...

... to ... 9-hour flights, HOBOKEN, N.J., Nov. 5 ... pine bark,extract from the French maritime pine tree, reduces jetlag in passengers ... and a,scoring system, showed Pycnogenol(R) lowered symptoms of jetlag such as,fatigue, headaches, ...

... Nov. 5 CuraGen Corporation,(Nasdaq: CRGN ), a ... Timothy M. Shannon, President and Chief,Executive Officer, will present ... Investment Conference on Wednesday, November 12, 2008, at,3:15 p.m. ... New York Palace,Hotel in New York, NY., Access ...

Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health Cornerstone Therapeutics Announces New Board of Directors CardiacAssist, Inc. Announces Record Breaking Site Activity and Financial Results Almost Family Reports Third Quarter 2008 Results Study Shows Pine Bark Reduces Jetlag CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...

(Date:5/23/2013)... , May 23, 2013 BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...

(Date:5/23/2013)... and PARIS , May ... ), a leading developer and manufacturer of precision guided ... of coronary and peripheral vascular disease, today announced preliminary ... asodilator I ndependent S tenosis E ... clinical trial session at EuroPCR 2013. These prospective results ...

Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9 Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5

[0] Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share [0] BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress [0] Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013

... A leader in healthcare, Henry Ford Health System will ... representing a "breakthrough" designed to improve treatment outcomes and ... admissions due to poor medication management by patients. ... programmable timers with Rexam prescription vials, which give audio ...

... BIOD ) today announced that it has entered into ... of its common stock and warrants to purchase 2,398,200 shares ... being sold as units, with each unit consisting of one ... share of common stock. The investors have ...

Cached Medicine Technology:Pharmacovigilance Breakthrough: Henry Ford Health System Partners with Rexam and Med Time Technology to Remind Patients to Take Prescription Medication "As Prescribed" to reduce $300 Billion National Healthcare Problem 2 Biodel to Raise $9.4 Million Through Registered Direct Offering 2 Biodel to Raise $9.4 Million Through Registered Direct Offering 3

Pharmacovigilance Breakthrough: Henry Ford Health System Partners with Rexam and Med Time Technology to Remind Patients to Take Prescription Medication "As Prescribed" to reduce $300 Billion National Healthcare Problem Biodel to Raise $9.4 Million Through Registered Direct Offering

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....

... an independent laboratory to ... of Federal Standard 209E. ... confort, reduces fatique and ... meets Class 100 particle ...

Medicine Products:

4V62 4V42-R 4V41-R Class 100 Chair